HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intrarectal administration of milk fat globule epidermal growth factor-8 protein ameliorates murine experimental colitis.

Abstract
Milk fat globule epidermal growth factor-8 (MFG-E8) promotes phagocytic clearance of apoptotic cells to maintain normal tissue homeostasis. However, its functions in intestinal inflammatory disorders are unknown. Since the pathogenesis of those disorders are due to abnormal interactions between intestinal epithelial cells (IECs) and microbial pathogens, we analyzed the effects of MFG-E8 on IECs to determine its protective role in murine experimental colitis. Expression of αvβ3-integrin in Colon-26 cells was examined by RT-PCR and immunostaining. Colon-26 cells were pretreated with recombinant wild-type and mutant MFG-E8 proteins, following stimulation with flagellin as an inducer of innate immunity, and the effects of the recombinant proteins on inhibition of nuclear factor-κB (NF-κB) and inflammatory cytokine production in flagellin-stimulated Colon-26 cells were determined using a luciferase assay and EIA, respectively. Experimental colitis was induced in mice by intrarectal administration of trinitrobenzene sulfonic acid (TNBS). Recombinant proteins were then intrarectally administered into TNBS-induced colitic mice, after which disease activity parameters (body weight, colon length, histological score), as well as interleukin (IL)-6 and MIP-2 levels were determined in inflamed tissues. Flagellin-induced inflammatory cytokine production in vitro was significantly downregulated via αvβ3-integrin following pretreatment with wild-type MFG-E8 due to inhibition of NF-κB activation. In vivo, intrarectal treatment with wild-type MFG-E8, but not its mutant counterpart, significantly inhibited body weight loss, colon shortening and histological inflammation induced by TNBS administration. Our findings suggest that MFG-E8 has anti-inflammatory effects on flagellin-induced inflamed intestinal epithelial cells and may be a useful therapeutic agent for colitis.
AuthorsAya Otani, Shunji Ishihara, Md Monowar Aziz, Naoki Oshima, Yoshiyuki Mishima, Ichiro Moriyama, Takafumi Yuki, Yuji Amano, Md Mesbahm Uddin Ansary, Yoshikazu Kinoshita
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 29 Issue 3 Pg. 349-56 (Mar 2012) ISSN: 1791-244X [Electronic] Greece
PMID22200667 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Infective Agents
  • Antigens, Surface
  • Cytokines
  • Integrin alpha Chains
  • Integrin beta Chains
  • Mfge8 protein, mouse
  • Milk Proteins
  • NF-kappa B
Topics
  • Administration, Rectal
  • Animals
  • Anti-Infective Agents (administration & dosage)
  • Antigens, Surface (administration & dosage, genetics)
  • Cell Line, Tumor
  • Colitis (chemically induced, drug therapy, genetics)
  • Colon (metabolism, pathology)
  • Cytokines (biosynthesis)
  • Disease Models, Animal
  • Inflammation (drug therapy, metabolism, pathology)
  • Integrin alpha Chains (genetics, metabolism)
  • Integrin beta Chains (genetics, metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Milk Proteins (administration & dosage, genetics)
  • NF-kappa B (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: